ATHA

Athira Pharma, Inc. - Common Stock (ATHA)

About Athira Pharma, Inc. - Common Stock (ATHA)

Athira Pharma, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline includes ATH-1017, ATH-1019/20, and ATH-1018. The company was founded by Leen Kawas, John Wright, Lewis Rumpler, and Joseph Harding in March 2011 and is headquartered in Bothell, WA.

Details

Daily high

$7.25

Daily low

$6.37

Price at open

$6.71

52 Week High

$8.36

52 Week Low

$2.20

Market cap

27.5M

Dividend yield

0.00%

Volume

1.4M

Avg. volume

3.3M

P/E ratio

-.72

Athira Pharma, Inc. - Common Stock News